{"protocolSection": {"identificationModule": {"nctId": "NCT00649389", "orgStudyIdInfo": {"id": "CS8635-A-U301"}, "organization": {"fullName": "Daiichi Sankyo", "class": "INDUSTRY"}, "briefTitle": "Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension", "officialTitle": "A Randomized, Double-Blind, Parallel Group Study Evaluating the Efficacy and Safety of Co-Administration of a Triple Combination Therapy of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Subjects With Hypertension"}, "statusModule": {"statusVerifiedDate": "2010-08", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-05"}, "primaryCompletionDateStruct": {"date": "2009-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2009-12", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-03-28", "studyFirstSubmitQcDate": "2008-03-31", "studyFirstPostDateStruct": {"date": "2008-04-01", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2010-08-09", "resultsFirstSubmitQcDate": "2010-08-09", "resultsFirstPostDateStruct": {"date": "2010-09-01", "type": "ESTIMATED"}, "dispFirstSubmitDate": "2010-04-07", "dispFirstSubmitQcDate": "2010-04-07", "dispFirstPostDateStruct": {"date": "2010-04-09", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2018-12-20", "lastUpdatePostDateStruct": {"date": "2019-01-09", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"oldNameTitle": "Executive Director Clinical Development", "oldOrganization": "Daiichi Sankyo Inc."}, "leadSponsor": {"name": "Daiichi Sankyo", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "To determine the effectiveness of four different strength combinations of three approved anti-hypertension therapies (olmesartan medoxomil, amlodipine, and hydrochlorothiazide) for lowering blood pressure."}, "conditionsModule": {"conditions": ["Hypertension"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 2500, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "OM40/AML10", "type": "EXPERIMENTAL", "description": "olmesartan medoxomil 40mg and amlodipine 10mg", "interventionNames": ["Drug: Olmesartan medoxomil", "Drug: Amlodipine"]}, {"label": "OM40/HCTZ25", "type": "ACTIVE_COMPARATOR", "description": "olmesartan medoxomil 40mg and hydrochlorothiazide 25mg", "interventionNames": ["Drug: Olmesartan medoxomil", "Drug: Hydrochlorothiazide"]}, {"label": "AML10/HCTZ25", "type": "ACTIVE_COMPARATOR", "description": "amlodipine 10mg and hydrochlorothiazide 25mg", "interventionNames": ["Drug: Amlodipine", "Drug: Hydrochlorothiazide"]}, {"label": "OM40/AML10/HCTZ25", "type": "ACTIVE_COMPARATOR", "description": "olmesartan medoxomil 40mg, amlodipine 10mg, and hydrochlorothiazide 25mg", "interventionNames": ["Drug: Olmesartan medoxomil", "Drug: Amlodipine", "Drug: Hydrochlorothiazide"]}], "interventions": [{"type": "DRUG", "name": "Olmesartan medoxomil", "description": "40mg olmesartan medoxomil", "armGroupLabels": ["OM40/AML10", "OM40/AML10/HCTZ25", "OM40/HCTZ25"], "otherNames": ["Benicar"]}, {"type": "DRUG", "name": "Amlodipine", "description": "Amlodipine 10mg", "armGroupLabels": ["AML10/HCTZ25", "OM40/AML10", "OM40/AML10/HCTZ25"], "otherNames": ["Norvasc"]}, {"type": "DRUG", "name": "Hydrochlorothiazide", "description": "Hydrochlorothiazide 25mg", "armGroupLabels": ["AML10/HCTZ25", "OM40/AML10/HCTZ25", "OM40/HCTZ25"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change From Baseline to Week 12 in Seated Diastolic Blood Pressure (SeDBP).", "timeFrame": "baseline to 12 weeks"}], "secondaryOutcomes": [{"measure": "Percentage of Subjects Who Reached Blood Pressure Goal (<140/90 mmHg; <130/80 mmHg for Subjects With Diabetes, Chronic Renal Disease, or Chronic Cardiovascular Disease)by 12 Weeks", "timeFrame": "Baseline to 12 weeks"}, {"measure": "Change in Mean 24-hour Ambulatory Blood Pressure From Baseline to Week 12 or Early Termination", "timeFrame": "Baseline to 12 weeks or early termination"}, {"measure": "Change in Seated Systolic Blood Pressure From Baseline to Week 12", "timeFrame": "Baseline to week 12"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Demonstrable hypertension defined as mean sitting trough cuff blood pressure \u2265 140/100 mmHg (SeSBP \u2265 140 mmHg and SeDBP \u2265 100mmHg) or mean sitting trough cuff BP \u2265 160/90 mmHg (SeSBP \u2265 160 mmHg and SeDBP \u2265 90mmHg).\n* Male or female newly diagnosed hypertensive subjects or currently on hypertension medication.\n\n  * Negative urine pregnancy test at screening\n  * Not lactating\n  * Do not plan to become pregnant during the study\n  * Will practice birth control throughout the study by the following: oral or patch contraceptive, injectable or implantable contraceptive medication, intrauterine device, diaphragm or female condom plus spermicide\n\n    * Non childbearing potential must be classified by one of the following criteria\n    * Had a hysterectomy or tubal ligation at least 6 months prior to consent\n    * Has been postmenopausal for a least 1 year\n\nExclusion Criteria:\n\n* Mean sitting trough cuff DBP \\<90 mmHg or mean sitting trough cuff SBP \\<140 mmHg (off antihypertensive medication).\n* Subjects with uncontrolled hypertension taking multiple antihypertensive therapies (at the discretion of the investigator).\n* Signs or symptoms which could exacerbate the occurrence of hypotension such as volume and salt depletion.\n* History of hypertensive encephalopathy, stroke or transient ischemic attack (TIA).\n* Participation in another clinical trial involving an investigational drug within one month prior to screening.\n* History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina within the past 6 months.\n* Any history of New York Heart Association Class III or IV congestive heart failure (CHF). A history of New York Heart Association Class I or II CHF may be exclusionary at the discretion of the investigator.\n* History of secondary hypertension including renal disease, pheochromocytoma, or Cushing's syndrome.\n* Uncorrected coarctation of the aorta, bilateral renal artery stenosis, or unilateral renal artery stenosis in a solitary kidney.\n* Evidence of symptomatic resting bradycardia.\n* Evidence of hemodynamically significant cardiac valvular disease.\n* Presence of heart block greater than first degree atrioventricular block, chronic atrial fibrillation or flutter.\n* Uncontrolled Type I or Type II diabetes defined as HbA1c \\>9.0%. Diabetics must have documentation of HbA1c within 6 months of the Screening Visit. Undocumented subjects must have their HbA1c assessed prior to randomization. Note: Subjects with Type I or Type II diabetes controlled with insulin, diet or oral hypoglycemic agents on a stable dose for at least 30 days may be included.\n* Evidence of liver disease as indicated by ALT and AST and/or total bilirubin \\>3 times the upper limit of normal.\n* Severe renal insufficiency defined as a creatinine clearance (based on the Cockcroft-Gault formula) of \\<30 mL/min.\n* Clinically significant laboratory elevations at Visit 1 that compromise subject safety, based on the investigator's judgment. Consideration should take into account the potential laboratory effects of the component blinded therapies.\n* Positive for any one of the following tests: hepatitis B surface antigen, hepatitis C antibody (confirmed by radio immunobinding assay, RIBA) or HIV antibody (confirmed by western blot assay).\n* Subjects with malignancy during the past 2 years excluding squamous cell or basal cell carcinoma of the skin.\n* Known allergy to any of the medications used in the study.\n* Subjects who require or are taking any concomitant medication, which may interfere with the objectives of the study (Refer to Section 5.2 for a listing of excluded medications).\n* Pregnant or lactating females.\n* Current history of drug or alcohol abuse.\n* A subject with any medical condition, which in the judgment of the Investigator would jeopardize the evaluation of efficacy or safety and/or constitute a significant safety risk to the subject.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "80 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"city": "Birmingham", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"city": "Columbiana", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.17817, "lon": -86.60721}}, {"city": "Gulf Shores", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 30.24604, "lon": -87.70082}}, {"city": "Hoover", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.40539, "lon": -86.81138}}, {"city": "Huntsville", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 34.7304, "lon": -86.58594}}, {"city": "Mobile", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 30.69436, "lon": -88.04305}}, {"city": "Montgomery", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 32.36681, "lon": -86.29997}}, {"city": "Muscle Shoals", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 34.74481, "lon": -87.66753}}, {"city": "Tuscumbia", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 34.7312, "lon": -87.70253}}, {"city": "Chandler", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.30616, "lon": -111.84125}}, {"city": "Goodyear", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.43532, "lon": -112.35821}}, {"city": "Lake Havasu City", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 34.4839, "lon": -114.32245}}, {"city": "Mesa", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.42227, "lon": -111.82264}}, {"city": "Peoria", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.5806, "lon": -112.23738}}, {"city": "Phoenix", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"city": "Scottsdale", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.50921, "lon": -111.89903}}, {"city": "Tucson", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 32.22174, "lon": -110.92648}}, {"city": "Hot Springs", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.5037, "lon": -93.05518}}, {"city": "Jonesboro", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 35.8423, "lon": -90.70428}}, {"city": "Little Rock", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"city": "North Little Rock", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.76954, "lon": -92.26709}}, {"city": "Searcy", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 35.25064, "lon": -91.73625}}, {"city": "Anaheim", "state": "California", "country": "United States", "geoPoint": {"lat": 33.83529, "lon": -117.9145}}, {"city": "Beverly Hills", "state": "California", "country": "United States", "geoPoint": {"lat": 34.07362, "lon": -118.40036}}, {"city": "Buena Park", "state": "California", "country": "United States", "geoPoint": {"lat": 33.86751, "lon": -117.99812}}, {"city": "Burbank", "state": "California", "country": "United States", "geoPoint": {"lat": 34.18084, "lon": -118.30897}}, {"city": "Carmichael", "state": "California", "country": "United States", "geoPoint": {"lat": 38.61713, "lon": -121.32828}}, {"city": "Chino", "state": "California", "country": "United States", "geoPoint": {"lat": 34.01223, "lon": -117.68894}}, {"city": "Chula Vista", "state": "California", "country": "United States", "geoPoint": {"lat": 32.64005, "lon": -117.0842}}, {"city": "Escondido", "state": "California", "country": "United States", "geoPoint": {"lat": 33.11921, "lon": -117.08642}}, {"city": "Greenbrae", "state": "California", "country": "United States", "geoPoint": {"lat": 37.94854, "lon": -122.5247}}, {"city": "Hollywood", "state": "California", "country": "United States", "geoPoint": {"lat": 34.09834, "lon": -118.32674}}, {"city": "Huntington Park", "state": "California", "country": "United States", "geoPoint": {"lat": 33.98168, "lon": -118.22507}}, {"city": "Long Beach", "state": "California", "country": "United States", "geoPoint": {"lat": 33.76696, "lon": -118.18923}}, {"city": "Los Angeles", "state": "California", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"city": "Los Gatos", "state": "California", "country": "United States", "geoPoint": {"lat": 37.22661, "lon": -121.97468}}, {"city": "Merced", "state": "California", "country": "United States", "geoPoint": {"lat": 37.30216, "lon": -120.48297}}, {"city": "National City", "state": "California", "country": "United States", "geoPoint": {"lat": 32.67811, "lon": -117.0992}}, {"city": "Orange", "state": "California", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -117.85311}}, {"city": "Roseville", "state": "California", "country": "United States", "geoPoint": {"lat": 38.75212, "lon": -121.28801}}, {"city": "San Diego", "state": "California", "country": "United States", "geoPoint": {"lat": 32.71533, "lon": -117.15726}}, {"city": "San Jose", "state": "California", "country": "United States", "geoPoint": {"lat": 37.33939, "lon": -121.89496}}, {"city": "Santa Ana", "state": "California", "country": "United States", "geoPoint": {"lat": 33.74557, "lon": -117.86783}}, {"city": "Santa Monica", "state": "California", "country": "United States", "geoPoint": {"lat": 34.01945, "lon": -118.49119}}, {"city": "Temecula", "state": "California", "country": "United States", "geoPoint": {"lat": 33.49364, "lon": -117.14836}}, {"city": "West Palm Beach", "state": "California", "country": "United States"}, {"city": "Westlake Village", "state": "California", "country": "United States", "geoPoint": {"lat": 34.14584, "lon": -118.80565}}, {"city": "Denver", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"city": "Golden", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.75554, "lon": -105.2211}}, {"city": "Pueblo", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 38.25445, "lon": -104.60914}}, {"city": "Wheat Ridge", "state": "Colorado", "country": "United States", "geoPoint": {"lat": 39.7661, "lon": -105.07721}}, {"city": "Danbury", "state": "Connecticut", "country": "United States", "geoPoint": {"lat": 41.39482, "lon": -73.45401}}, {"city": "Milford", "state": "Connecticut", "country": "United States", "geoPoint": {"lat": 41.22232, "lon": -73.0565}}, {"city": "Stamford", "state": "Connecticut", "country": "United States", "geoPoint": {"lat": 41.05343, "lon": -73.53873}}, {"city": "Trumbull", "state": "Connecticut", "country": "United States", "geoPoint": {"lat": 41.24287, "lon": -73.20067}}, {"city": "Waterbury", "state": "Connecticut", "country": "United States", "geoPoint": {"lat": 41.55815, "lon": -73.0515}}, {"city": "Aventura", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.95648, "lon": -80.13921}}, {"city": "Boynton Beach", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.52535, "lon": -80.06643}}, {"city": "Bradenton", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.49893, "lon": -82.57482}}, {"city": "Brooksville", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.55554, "lon": -82.38991}}, {"city": "Cape Coral", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.56285, "lon": -81.94953}}, {"city": "Clearwater", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.96585, "lon": -82.8001}}, {"city": "Coral Gables", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.72149, "lon": -80.26838}}, {"city": "Crystal River", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.90248, "lon": -82.5926}}, {"city": "Daytona Beach", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.21081, "lon": -81.02283}}, {"city": "Deerfield Beach", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.31841, "lon": -80.09977}}, {"city": "DeLand", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.02832, "lon": -81.30312}}, {"city": "Delray Beach", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.46146, "lon": -80.07282}}, {"city": "Dunnellon", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.04914, "lon": -82.46093}}, {"city": "Fort Myers", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.62168, "lon": -81.84059}}, {"city": "Hialeah", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.8576, "lon": -80.27811}}, {"city": "Hollywood", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.0112, "lon": -80.14949}}, {"city": "Jacksonville", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"city": "Jupiter", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.93422, "lon": -80.09421}}, {"city": "Kissimmee", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.30468, "lon": -81.41667}}, {"city": "Largo", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.90979, "lon": -82.78842}}, {"city": "Merritt Island", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.53917, "lon": -80.672}}, {"city": "Miami", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"city": "New Port Richey", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.24418, "lon": -82.71927}}, {"city": "Ocala", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.1872, "lon": -82.14009}}, {"city": "Palm Harbor", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.07807, "lon": -82.76371}}, {"city": "Pembroke Pines", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.00315, "lon": -80.22394}}, {"city": "Plantation", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.13421, "lon": -80.23184}}, {"city": "Port Orange", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.13832, "lon": -80.99561}}, {"city": "Saint Petersburg", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.77086, "lon": -82.67927}}, {"city": "Sarasota", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.33643, "lon": -82.53065}}, {"city": "South Miami", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.7076, "lon": -80.29338}}, {"city": "Tampa", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"city": "W. Bradenton", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.50254, "lon": -82.61399}}, {"city": "Atlanta", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"city": "Augusta", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 33.47097, "lon": -81.97484}}, {"city": "Columbus", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 32.46098, "lon": -84.98771}}, {"city": "Savannah", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 32.08354, "lon": -81.09983}}, {"city": "Suwanee", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 34.05149, "lon": -84.0713}}, {"city": "Waycross", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 31.21368, "lon": -82.3557}}, {"city": "Idaho Falls", "state": "Idaho", "country": "United States", "geoPoint": {"lat": 43.46658, "lon": -112.03414}}, {"city": "Chicago", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"city": "Gurnee", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 42.3703, "lon": -87.90202}}, {"city": "Libertyville", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 42.28308, "lon": -87.95313}}, {"city": "Evansville", "state": "Indiana", "country": "United States", "geoPoint": {"lat": 37.97476, "lon": -87.55585}}, {"city": "Indianapolis", "state": "Indiana", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"city": "Newton", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 38.04668, "lon": -97.34504}}, {"city": "Shawnee Mission", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 39.04167, "lon": -94.72024}}, {"city": "Wichita", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 37.69224, "lon": -97.33754}}, {"city": "Madisonville", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.3281, "lon": -87.49889}}, {"city": "Mount Sterling", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 38.05647, "lon": -83.94326}}, {"city": "Munfordville", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.27228, "lon": -85.89108}}, {"city": "Paducah", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.08339, "lon": -88.60005}}, {"city": "Kenner", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 29.99409, "lon": -90.24174}}, {"city": "Lake Charles", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 30.21309, "lon": -93.2044}}, {"city": "Metairie", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 29.98409, "lon": -90.15285}}, {"city": "New Orleans", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"city": "Shreveport", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 32.52515, "lon": -93.75018}}, {"city": "Baltimore", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"city": "Elkridge", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 39.21261, "lon": -76.71358}}, {"city": "Oxon Hill", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 38.80345, "lon": -76.9897}}, {"city": "Brockton", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 42.08343, "lon": -71.01838}}, {"city": "Haverhill", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 42.7762, "lon": -71.07728}}, {"city": "West Yarmouth", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 41.65011, "lon": -70.24113}}, {"city": "Benzonia", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 44.62139, "lon": -86.09926}}, {"city": "Clarkston", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.73586, "lon": -83.41883}}, {"city": "Paw Paw", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.21782, "lon": -85.89112}}, {"city": "Southfield", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.47337, "lon": -83.22187}}, {"city": "Traverse City", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 44.76306, "lon": -85.62063}}, {"city": "Waterford", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.69303, "lon": -83.41181}}, {"city": "Brooklyn Center", "state": "Minnesota", "country": "United States", "geoPoint": {"lat": 45.07608, "lon": -93.33273}}, {"city": "Chaska", "state": "Minnesota", "country": "United States", "geoPoint": {"lat": 44.78941, "lon": -93.60218}}, {"city": "Saint Paul", "state": "Minnesota", "country": "United States", "geoPoint": {"lat": 44.94441, "lon": -93.09327}}, {"city": "Olive Branch", "state": "Mississippi", "country": "United States", "geoPoint": {"lat": 34.96176, "lon": -89.82953}}, {"city": "Florissant", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.78922, "lon": -90.32261}}, {"city": "Kansas City", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 39.09973, "lon": -94.57857}}, {"city": "Saint Louis", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"city": "Butte", "state": "Montana", "country": "United States", "geoPoint": {"lat": 46.00382, "lon": -112.53474}}, {"city": "Missoula", "state": "Montana", "country": "United States", "geoPoint": {"lat": 46.87215, "lon": -113.994}}, {"city": "Broken Bow", "state": "Nebraska", "country": "United States", "geoPoint": {"lat": 41.40195, "lon": -99.63928}}, {"city": "North Platte", "state": "Nebraska", "country": "United States", "geoPoint": {"lat": 41.12389, "lon": -100.76542}}, {"city": "Las Vegas", "state": "Nevada", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"city": "Berlin", "state": "New Jersey", "country": "United States", "geoPoint": {"lat": 39.79123, "lon": -74.92905}}, {"city": "Elizabeth", "state": "New Jersey", "country": "United States", "geoPoint": {"lat": 40.66399, "lon": -74.2107}}, {"city": "Voorhees", "state": "New Jersey", "country": "United States", "geoPoint": {"lat": 40.48122, "lon": -74.48321}}, {"city": "Buffalo", "state": "New York", "country": "United States", "geoPoint": {"lat": 42.88645, "lon": -78.87837}}, {"city": "Manlius", "state": "New York", "country": "United States", "geoPoint": {"lat": 43.00201, "lon": -75.97686}}, {"city": "Mineola", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.74927, "lon": -73.64068}}, {"city": "New York", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"city": "Westfield", "state": "New York", "country": "United States", "geoPoint": {"lat": 42.32228, "lon": -79.5781}}, {"city": "Calabash", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 33.89073, "lon": -78.56834}}, {"city": "Charlotte", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"city": "Durham", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"city": "Hickory", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.73319, "lon": -81.3412}}, {"city": "High Point", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.95569, "lon": -80.00532}}, {"city": "Raleigh", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.7721, "lon": -78.63861}}, {"city": "Salisbury", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.67097, "lon": -80.47423}}, {"city": "Statesville", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.78264, "lon": -80.8873}}, {"city": "Tabor City", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 34.14878, "lon": -78.87669}}, {"city": "Winston-Salem", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.09986, "lon": -80.24422}}, {"city": "Fargo", "state": "North Dakota", "country": "United States", "geoPoint": {"lat": 46.87719, "lon": -96.7898}}, {"city": "Austintown", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.10172, "lon": -80.76452}}, {"city": "Cincinnati", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"city": "Cleveland", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"city": "Columbus", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"city": "Euclid", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.5931, "lon": -81.52679}}, {"city": "Franklin", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.55895, "lon": -84.30411}}, {"city": "Kettering", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.6895, "lon": -84.16883}}, {"city": "Lyndhurst", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.52005, "lon": -81.48873}}, {"city": "Marion", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 40.58867, "lon": -83.12852}}, {"city": "Mount Gilead", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 40.54923, "lon": -82.8274}}, {"city": "Wadsworth", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.02561, "lon": -81.72985}}, {"city": "Westlake", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.45532, "lon": -81.91792}}, {"city": "Norman", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 35.22257, "lon": -97.43948}}, {"city": "Oklahoma City", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"city": "Tulsa", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 36.15398, "lon": -95.99277}}, {"city": "Eugene", "state": "Oregon", "country": "United States", "geoPoint": {"lat": 44.05207, "lon": -123.08675}}, {"city": "Medford", "state": "Oregon", "country": "United States", "geoPoint": {"lat": 42.32652, "lon": -122.87559}}, {"city": "Portland", "state": "Oregon", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"city": "Beaver", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.69534, "lon": -80.30478}}, {"city": "Bensalem", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.10455, "lon": -74.95128}}, {"city": "Downingtown", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.0065, "lon": -75.70327}}, {"city": "Erie", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 42.12922, "lon": -80.08506}}, {"city": "Harleysville", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.27955, "lon": -75.38712}}, {"city": "Jenkintown", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.09594, "lon": -75.12517}}, {"city": "Jersey Shore", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 41.20202, "lon": -77.26442}}, {"city": "Penndel", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.15205, "lon": -74.91656}}, {"city": "Philadelphia", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"city": "Cranston", "state": "Rhode Island", "country": "United States", "geoPoint": {"lat": 41.77982, "lon": -71.43728}}, {"city": "East Providence", "state": "Rhode Island", "country": "United States", "geoPoint": {"lat": 41.81371, "lon": -71.37005}}, {"city": "Providence", "state": "Rhode Island", "country": "United States", "geoPoint": {"lat": 41.82399, "lon": -71.41283}}, {"city": "Anderson", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 34.50344, "lon": -82.65013}}, {"city": "Charleston", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"city": "Columbia", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 34.00071, "lon": -81.03481}}, {"city": "Murrells Inlet", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 33.551, "lon": -79.04143}}, {"city": "Orangeburg", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 33.49182, "lon": -80.85565}}, {"city": "Rapid City", "state": "South Dakota", "country": "United States", "geoPoint": {"lat": 44.08054, "lon": -103.23101}}, {"city": "Bristol", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.59511, "lon": -82.18874}}, {"city": "Fayetteville", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 35.15203, "lon": -86.57055}}, {"city": "Knoxville", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 35.96064, "lon": -83.92074}}, {"city": "Memphis", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 35.14953, "lon": -90.04898}}, {"city": "Nashville", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"city": "New Tazewell", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.44258, "lon": -83.59963}}, {"city": "Tullahoma", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 35.36202, "lon": -86.20943}}, {"city": "Austin", "state": "Texas", "country": "United States", "geoPoint": {"lat": 30.26715, "lon": -97.74306}}, {"city": "Bedford", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.84402, "lon": -97.14307}}, {"city": "Corpus Christi", "state": "Texas", "country": "United States", "geoPoint": {"lat": 27.80058, "lon": -97.39638}}, {"city": "Houston", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"city": "Hurst", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.82346, "lon": -97.17057}}, {"city": "Lake Jackson", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.03386, "lon": -95.43439}}, {"city": "Midland", "state": "Texas", "country": "United States", "geoPoint": {"lat": 31.99735, "lon": -102.07791}}, {"city": "Plano", "state": "Texas", "country": "United States", "geoPoint": {"lat": 33.01984, "lon": -96.69889}}, {"city": "Round Rock", "state": "Texas", "country": "United States", "geoPoint": {"lat": 30.50826, "lon": -97.6789}}, {"city": "San Antonio", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"city": "Spring", "state": "Texas", "country": "United States", "geoPoint": {"lat": 30.07994, "lon": -95.41716}}, {"city": "Sugar Land", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.61968, "lon": -95.63495}}, {"city": "Temple", "state": "Texas", "country": "United States", "geoPoint": {"lat": 31.09823, "lon": -97.34278}}, {"city": "Waco", "state": "Texas", "country": "United States", "geoPoint": {"lat": 31.54933, "lon": -97.14667}}, {"city": "Bountiful", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.88939, "lon": -111.88077}}, {"city": "Magna", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.70911, "lon": -112.10161}}, {"city": "Midvale", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.61106, "lon": -111.89994}}, {"city": "Salt Lake City", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"city": "Sandy", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.59161, "lon": -111.8841}}, {"city": "Saratoga Springs", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.34912, "lon": -111.90466}}, {"city": "West Jordan", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.60967, "lon": -111.9391}}, {"city": "Norfolk", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 36.84681, "lon": -76.28522}}, {"city": "Richmond", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"city": "Suffolk", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 36.72836, "lon": -76.58496}}, {"city": "Federal Way", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.32232, "lon": -122.31262}}, {"city": "Lakewood", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.17176, "lon": -122.51846}}, {"city": "Tacoma", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.25288, "lon": -122.44429}}, {"city": "Kenosha", "state": "Wisconsin", "country": "United States", "geoPoint": {"lat": 42.58474, "lon": -87.82119}}, {"city": "Madison", "state": "Wisconsin", "country": "United States", "geoPoint": {"lat": 43.07305, "lon": -89.40123}}, {"city": "Ciales", "country": "Puerto Rico", "geoPoint": {"lat": 18.33606, "lon": -66.46878}}, {"city": "Guayama", "country": "Puerto Rico", "geoPoint": {"lat": 17.98413, "lon": -66.11378}}, {"city": "Ponce", "country": "Puerto Rico", "geoPoint": {"lat": 18.01108, "lon": -66.61406}}, {"city": "Rio Piedras", "country": "Puerto Rico", "geoPoint": {"lat": 18.39745, "lon": -66.04989}}]}, "referencesModule": {"references": [{"pmid": "23110471", "type": "DERIVED", "citation": "Kereiakes DJ, Chrysant SG, Izzo JL Jr, Littlejohn T 3rd, Melino M, Lee J, Fernandez V, Heyrman R. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study. Cardiovasc Diabetol. 2012 Oct 30;11:134. doi: 10.1186/1475-2840-11-134."}, {"pmid": "22799613", "type": "DERIVED", "citation": "Chrysant SG, Littlejohn T 3rd, Izzo JL Jr, Kereiakes DJ, Oparil S, Melino M, Lee J, Fernandez V, Heyrman R. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study. Am J Cardiovasc Drugs. 2012 Aug 1;12(4):233-43. doi: 10.1007/BF03261832."}, {"pmid": "20678674", "type": "DERIVED", "citation": "Oparil S, Melino M, Lee J, Fernandez V, Heyrman R. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study. Clin Ther. 2010 Jul;32(7):1252-69. doi: 10.1016/j.clinthera.2010.07.008."}, {"pmid": "19751459", "type": "DERIVED", "citation": "Chrysant SG, Oparil S, Melino M, Karki S, Lee J, Heyrman R. Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension. J Clin Hypertens (Greenwich). 2009 Sep;11(9):475-82. doi: 10.1111/j.1751-7176.2009.00159.x."}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "De-identified individual participant data (IPD) and applicable supporting clinical trial documents may be available upon request at https://vivli.org/. In cases where clinical trial data and supporting documents are provided pursuant to our company policies and procedures, Daiichi Sankyo will continue to protect the privacy of our clinical trial participants. Details on data sharing criteria and the procedure for requesting access can be found at this web address: https://vivli.org/ourmember/daiichi-sankyo/", "infoTypes": ["STUDY_PROTOCOL", "SAP", "ICF", "CSR", "ANALYTIC_CODE"], "timeFrame": "Studies for which the medicine and indication have received European Union (EU) and United States (US), and/or Japan (JP) marketing approval on or after 01 January 2014 or by the US or EU or JP Health Authorities when regulatory submissions in all regions are not planned and after the primary study results have been accepted for publication.", "accessCriteria": "Formal request from qualified scientific and medical researchers on IPD and clinical study documents from clinical trials supporting products submitted and licensed in the United States, the European Union and/or Japan from 01 January 2014 and beyond for the purpose of conducting legitimate research. This must be consistent with the principle of safeguarding study participants' privacy and consistent with provision of informed consent.", "url": "https://vivli.org/ourmember/daiichi-sankyo/"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Duration of the study was 57 weeks with 52 weeks of treatment. This included 3-week stabilization/washout (Period I), 12-week double blind treatment (Period II), 40 week open label treatment (Period III), and 2-week post treatment follow-up (Period IV).", "recruitmentDetails": "First subject first visit 12 May 2008. Last subject last follow-up 27 Feb 2009. 317 sites in USA and Puerto Rico. Planned: 2400 subjects (600 per treatment arm). Enrolled: 6724 subjects. Randomized: 2492 subjects.", "groups": [{"id": "FG000", "title": "OM40/AML10", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg tablets once daily."}, {"id": "FG001", "title": "OM40/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "FG002", "title": "AML10/HCTZ25", "description": "Double blind treatment Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "FG003", "title": "OM40/AML10/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg, tablets once daily."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "628"}, {"groupId": "FG001", "numSubjects": "637"}, {"groupId": "FG002", "numSubjects": "600"}, {"groupId": "FG003", "numSubjects": "627"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "557"}, {"groupId": "FG001", "numSubjects": "531"}, {"groupId": "FG002", "numSubjects": "512"}, {"groupId": "FG003", "numSubjects": "516"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "71"}, {"groupId": "FG001", "numSubjects": "106"}, {"groupId": "FG002", "numSubjects": "88"}, {"groupId": "FG003", "numSubjects": "111"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "22"}, {"groupId": "FG001", "numSubjects": "46"}, {"groupId": "FG002", "numSubjects": "38"}, {"groupId": "FG003", "numSubjects": "48"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "17"}, {"groupId": "FG002", "numSubjects": "21"}, {"groupId": "FG003", "numSubjects": "26"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "11"}, {"groupId": "FG001", "numSubjects": "13"}, {"groupId": "FG002", "numSubjects": "9"}, {"groupId": "FG003", "numSubjects": "8"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "20"}, {"groupId": "FG001", "numSubjects": "21"}, {"groupId": "FG002", "numSubjects": "19"}, {"groupId": "FG003", "numSubjects": "23"}]}, {"type": "Other", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "9"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "6"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "OM40/AML10", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg tablets once daily."}, {"id": "BG001", "title": "OM40/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "BG002", "title": "AML10/HCTZ25", "description": "Double blind treatment Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "BG003", "title": "OM40/AML10/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg, tablets once daily."}, {"id": "BG004", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "628"}, {"groupId": "BG001", "value": "637"}, {"groupId": "BG002", "value": "600"}, {"groupId": "BG003", "value": "627"}, {"groupId": "BG004", "value": "2492"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "508"}, {"groupId": "BG001", "value": "505"}, {"groupId": "BG002", "value": "504"}, {"groupId": "BG003", "value": "504"}, {"groupId": "BG004", "value": "2021"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "120"}, {"groupId": "BG001", "value": "132"}, {"groupId": "BG002", "value": "96"}, {"groupId": "BG003", "value": "123"}, {"groupId": "BG004", "value": "471"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "55.1", "spread": "10.93"}, {"groupId": "BG001", "value": "55.9", "spread": "10.78"}, {"groupId": "BG002", "value": "54.6", "spread": "10.82"}, {"groupId": "BG003", "value": "54.7", "spread": "11.22"}, {"groupId": "BG004", "value": "55.1", "spread": "10.94"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "303"}, {"groupId": "BG001", "value": "298"}, {"groupId": "BG002", "value": "266"}, {"groupId": "BG003", "value": "307"}, {"groupId": "BG004", "value": "1174"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "325"}, {"groupId": "BG001", "value": "339"}, {"groupId": "BG002", "value": "334"}, {"groupId": "BG003", "value": "320"}, {"groupId": "BG004", "value": "1318"}]}]}]}, {"title": "Race/Ethnicity, Customized", "description": "Race of participants as selected by participant. Participants were allowed to choose more than one race category; therefore, the total for an arm may be greater than the number of participants", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "American Indian/Alaskan Native", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "1"}, {"groupId": "BG004", "value": "9"}]}]}, {"title": "Asian", "categories": [{"measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "7"}, {"groupId": "BG003", "value": "19"}, {"groupId": "BG004", "value": "49"}]}]}, {"title": "Hawaiian/Pacific Islander", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "2"}, {"groupId": "BG004", "value": "4"}]}]}, {"title": "Black/African American", "categories": [{"measurements": [{"groupId": "BG000", "value": "181"}, {"groupId": "BG001", "value": "200"}, {"groupId": "BG002", "value": "192"}, {"groupId": "BG003", "value": "184"}, {"groupId": "BG004", "value": "757"}]}]}, {"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "431"}, {"groupId": "BG001", "value": "421"}, {"groupId": "BG002", "value": "391"}, {"groupId": "BG003", "value": "415"}, {"groupId": "BG004", "value": "1658"}]}]}, {"title": "Unknown or Not Reported", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "5"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "15"}]}]}]}, {"title": "Diabetes Status", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "Diabetic", "categories": [{"measurements": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "99"}, {"groupId": "BG002", "value": "92"}, {"groupId": "BG003", "value": "96"}, {"groupId": "BG004", "value": "387"}]}]}, {"title": "Not diabetic", "categories": [{"measurements": [{"groupId": "BG000", "value": "528"}, {"groupId": "BG001", "value": "538"}, {"groupId": "BG002", "value": "508"}, {"groupId": "BG003", "value": "531"}, {"groupId": "BG004", "value": "2105"}]}]}]}, {"title": "Weight", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "95.9", "spread": "22.65"}, {"groupId": "BG001", "value": "96.1", "spread": "22.55"}, {"groupId": "BG002", "value": "96.1", "spread": "23.41"}, {"groupId": "BG003", "value": "96.0", "spread": "23.24"}, {"groupId": "BG004", "value": "96.0", "spread": "22.94"}]}]}]}, {"title": "Body Mass Index", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "Less than 30 kg/m2", "categories": [{"measurements": [{"groupId": "BG000", "value": "229"}, {"groupId": "BG001", "value": "238"}, {"groupId": "BG002", "value": "230"}, {"groupId": "BG003", "value": "240"}, {"groupId": "BG004", "value": "937"}]}]}, {"title": "Greater than or equal to 30 kg/m2", "categories": [{"measurements": [{"groupId": "BG000", "value": "399"}, {"groupId": "BG001", "value": "399"}, {"groupId": "BG002", "value": "370"}, {"groupId": "BG003", "value": "387"}, {"groupId": "BG004", "value": "1555"}]}]}]}, {"title": "Duration of hypertension", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "10.12", "spread": "9.865"}, {"groupId": "BG001", "value": "10.34", "spread": "9.826"}, {"groupId": "BG002", "value": "9.73", "spread": "8.983"}, {"groupId": "BG003", "value": "9.54", "spread": "9.558"}, {"groupId": "BG004", "value": "9.94", "spread": "9.571"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change From Baseline to Week 12 in Seated Diastolic Blood Pressure (SeDBP).", "populationDescription": "The full analysis set consists of subjects who received at least 1 dose of study medication and had a baseline and at least one post-dose assessment of SeDBP", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "baseline to 12 weeks", "groups": [{"id": "OG000", "title": "OM40/AML10", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg tablets once daily."}, {"id": "OG001", "title": "OM40/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "OG002", "title": "AML10/HCTZ25", "description": "Double blind treatment Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "OG003", "title": "OM40/AML10/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg, tablets once daily."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "624"}, {"groupId": "OG001", "value": "627"}, {"groupId": "OG002", "value": "593"}, {"groupId": "OG003", "value": "614"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-17.8", "spread": "9.47"}, {"groupId": "OG001", "value": "-16.5", "spread": "10.84"}, {"groupId": "OG002", "value": "-14.8", "spread": "8.78"}, {"groupId": "OG003", "value": "-21.5", "spread": "10.25"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "groupDescription": "All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG002", "OG003"], "groupDescription": "All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}]}, {"type": "SECONDARY", "title": "Percentage of Subjects Who Reached Blood Pressure Goal (<140/90 mmHg; <130/80 mmHg for Subjects With Diabetes, Chronic Renal Disease, or Chronic Cardiovascular Disease)by 12 Weeks", "populationDescription": "The full analysis set consists of subjects who received at least 1 dose of study medication and had a baseline and at least one post-dose assessment of seated diastolic blood pressure", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage of subjects", "timeFrame": "Baseline to 12 weeks", "groups": [{"id": "OG000", "title": "OM40/AML10", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg tablets once daily."}, {"id": "OG001", "title": "OM40/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "OG002", "title": "AML10/HCTZ25", "description": "Double blind treatment Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "OG003", "title": "OM40/AML10/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg, tablets once daily."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "624"}, {"groupId": "OG001", "value": "627"}, {"groupId": "OG002", "value": "593"}, {"groupId": "OG003", "value": "614"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "46.0"}, {"groupId": "OG001", "value": "46.6"}, {"groupId": "OG002", "value": "34.9"}, {"groupId": "OG003", "value": "64.3"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "groupDescription": "Each p-value was obtained from individual Cochran-Mantel-Haenszel tests stratified by age group, race group, and diabetic status comparing the triple combination therapy to each dual combination.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "Cochran-Mantel-Haenszel", "ciPctValue": "95"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Each p-value was obtained from individual Cochran-Mantel-Haenszel tests stratified by age group, race group, and diabetic status comparing the triple combination therapy to each dual combination.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "Cochran-Mantel-Haenszel", "ciPctValue": "95"}, {"groupIds": ["OG002", "OG003"], "groupDescription": "Each p-value was obtained from individual Cochran-Mantel-Haenszel tests stratified by age group, race group, and diabetic status comparing the triple combination therapy to each dual combination.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "Cochran-Mantel-Haenszel", "ciPctValue": "95"}]}, {"type": "SECONDARY", "title": "Change in Mean 24-hour Ambulatory Blood Pressure From Baseline to Week 12 or Early Termination", "populationDescription": "The ABPM Analysis Set included 440 subjects who provided consent to participate in the ABPM sub-study and who were to provide ABPM measurements prior to and after randomization. Those analyzed is the number who had values at both baseline and 12 weeks or early termination", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "Baseline to 12 weeks or early termination", "groups": [{"id": "OG000", "title": "OM40/AML10", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg tablets once daily."}, {"id": "OG001", "title": "OM40/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "OG002", "title": "AML10/HCTZ25", "description": "Double blind treatment Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "OG003", "title": "OM40/AML10/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg, tablets once daily."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "96"}, {"groupId": "OG001", "value": "101"}, {"groupId": "OG002", "value": "83"}, {"groupId": "OG003", "value": "100"}]}], "classes": [{"title": "Diastolic blood pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-13.9", "spread": "8.09"}, {"groupId": "OG001", "value": "-14.5", "spread": "8.73"}, {"groupId": "OG002", "value": "-10.7", "spread": "7.46"}, {"groupId": "OG003", "value": "-18.0", "spread": "8.11"}]}]}, {"title": "Systolic blood pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "-23.5", "spread": "11.80"}, {"groupId": "OG001", "value": "-23.9", "spread": "13.10"}, {"groupId": "OG002", "value": "-18.5", "spread": "10.67"}, {"groupId": "OG003", "value": "-30.3", "spread": "13.85"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "groupDescription": "Diastolic blood pressure: All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Diastolic blood pressure: All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG002", "OG003"], "groupDescription": "Diastolic blood pressure: All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG000", "OG003"], "groupDescription": "Systolic blood pressure: All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "Systolic blood pressure: All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG002", "OG003"], "groupDescription": "Systolic blood pressure: All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}]}, {"type": "SECONDARY", "title": "Change in Seated Systolic Blood Pressure From Baseline to Week 12", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mm Hg", "timeFrame": "Baseline to week 12", "groups": [{"id": "OG000", "title": "OM40/AML10", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg tablets once daily."}, {"id": "OG001", "title": "OM40/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "OG002", "title": "AML10/HCTZ25", "description": "Double blind treatment Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily."}, {"id": "OG003", "title": "OM40/AML10/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg, tablets once daily."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "624"}, {"groupId": "OG001", "value": "627"}, {"groupId": "OG002", "value": "593"}, {"groupId": "OG003", "value": "614"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-31.1", "spread": "15.44"}, {"groupId": "OG001", "value": "-31.2", "spread": "18.58"}, {"groupId": "OG002", "value": "-28.9", "spread": "15.12"}, {"groupId": "OG003", "value": "-38.1", "spread": "17.40"}]}]}], "analyses": [{"groupIds": ["OG000", "OG003"], "groupDescription": "All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG001", "OG003"], "groupDescription": "All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}, {"groupIds": ["OG002", "OG003"], "groupDescription": "All treatment comparisons were calculated as OM40/AML10/HCTZ25 minus the respective dual combination treatment group. Least-squares mean differences, SEs, and 2-sided p-values were obtained from an ANCOVA model with baseline blood pressure as a covariate, and fixed effects of treatment, age group, race group, and diabetic status.", "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "<0.0001", "statisticalMethod": "ANCOVA", "ciPctValue": "95"}]}]}, "adverseEventsModule": {"frequencyThreshold": "3", "timeFrame": "12 weeks", "description": "Safety was assessed at all study visits. Variables included adverse events, clinical laboratory tests, vital signs, ECGs, and physical examinations. The assessment of causality was based on the investigator's judgment.", "eventGroups": [{"id": "EG000", "title": "OM40/AML10", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg tablets once daily.", "seriousNumAffected": 9, "seriousNumAtRisk": 596, "otherNumAffected": 210, "otherNumAtRisk": 596}, {"id": "EG001", "title": "OM40/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily.", "seriousNumAffected": 7, "seriousNumAtRisk": 580, "otherNumAffected": 210, "otherNumAtRisk": 580}, {"id": "EG002", "title": "AML10/HCTZ25", "description": "Double blind treatment Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg tablets once daily.", "seriousNumAffected": 9, "seriousNumAtRisk": 552, "otherNumAffected": 212, "otherNumAtRisk": 552}, {"id": "EG003", "title": "OM40/AML10/HCTZ25", "description": "Double blind treatment olmesartan medoxomil (OM) 40 mg, Amlodipine (AML) 10 mg, Hydrochlorothiazide (HCTZ) 25 mg, tablets once daily.", "seriousNumAffected": 10, "seriousNumAtRisk": 574, "otherNumAffected": 237, "otherNumAtRisk": 574}], "seriousEvents": [{"term": "appendicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 11.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "arthritis bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "lobar pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "osteomyelitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "pyelonephritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "prostate cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 574}]}, {"term": "bladder cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "colon cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "renal cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "cerebrovasular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "ataxia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "cerebellar infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "hemiparesis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "peroneal nerve palsy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "coronary artery disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 574}]}, {"term": "acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "right ventricular failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "duodenitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "gastrointstial haemhorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "hiatus hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "rectal haemhorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "intervertebral disc degeneration", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "musculoskeletal chest pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "obstructive airways disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "sleep apnoea syndrome", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "fall", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "hip fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "vertebral injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "hypokalemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "hyponatraemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "acute prerenal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "hydronephrosis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "pulmonary artery atresia", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 574}]}, {"term": "hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}, {"term": "ovarian cyst", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 574}]}], "otherEvents": [{"term": "dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 29, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 58, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 17, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 57, "numAtRisk": 574}]}, {"term": "headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 42, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 38, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 33, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 37, "numAtRisk": 574}]}, {"term": "upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 26, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 18, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 14, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 16, "numAtRisk": 574}]}, {"term": "nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 20, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 16, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 20, "numAtRisk": 574}]}, {"term": "edema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 42, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 46, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 44, "numAtRisk": 574}]}, {"term": "fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 34, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 31, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 36, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 24, "numAtRisk": 574}]}, {"term": "muscle spasms", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 14, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 13, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 18, "numAtRisk": 574}]}, {"term": "nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 22, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 12, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 17, "numAtRisk": 574}]}, {"term": "hypokalemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (11.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 596}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 580}, {"groupId": "EG002", "numAffected": 25, "numAtRisk": 552}, {"groupId": "EG003", "numAffected": 4, "numAtRisk": 574}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Study site may not publish results of study until after coordinated multicenter publication has been submitted for publication or one year after study has ended, whichever occurs first. Therefore, study site will have the opportunity to publish results of study, provided that Daiichi Sankyo has had the opportunity to review and comment on study site's proposed publication prior to being submitted for publication with advice of company patent council and in accord with subject protection needs."}, "pointOfContact": {"title": "Howard Kessler", "organization": "Daiichi Sankyo", "email": "hmkessler@dsi.com", "phone": "732-590-5032"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-07-01"}, "conditionBrowseModule": {"meshes": [{"id": "D000006973", "term": "Hypertension"}], "ancestors": [{"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M10024", "name": "Hypertension", "asFound": "Hypertension", "relevance": "HIGH"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000017311", "term": "Amlodipine"}, {"id": "D000006852", "term": "Hydrochlorothiazide"}, {"id": "C000437965", "term": "Olmesartan"}, {"id": "D000068557", "term": "Olmesartan Medoxomil"}], "ancestors": [{"id": "D000000959", "term": "Antihypertensive Agents"}, {"id": "D000002121", "term": "Calcium Channel Blockers"}, {"id": "D000049990", "term": "Membrane Transport Modulators"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000077264", "term": "Calcium-Regulating Hormones and Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000014665", "term": "Vasodilator Agents"}, {"id": "D000004232", "term": "Diuretics"}, {"id": "D000045283", "term": "Natriuretic Agents"}, {"id": "D000049993", "term": "Sodium Chloride Symporter Inhibitors"}, {"id": "D000047228", "term": "Angiotensin II Type 1 Receptor Blockers"}, {"id": "D000057911", "term": "Angiotensin Receptor Antagonists"}], "browseLeaves": [{"id": "M19600", "name": "Amlodipine", "asFound": "Healthy Volunteers", "relevance": "HIGH"}, {"id": "M9910", "name": "Hydrochlorothiazide", "asFound": "Prescription", "relevance": "HIGH"}, {"id": "M91890", "name": "Olmesartan", "asFound": "Anticoagulation", "relevance": "HIGH"}, {"id": "M273", "name": "Olmesartan Medoxomil", "asFound": "Sleep hygiene", "relevance": "HIGH"}, {"id": "M4277", "name": "Antihypertensive Agents", "relevance": "LOW"}, {"id": "M5381", "name": "Calcium", "relevance": "LOW"}, {"id": "M5398", "name": "Calcium, Dietary", "relevance": "LOW"}, {"id": "M5384", "name": "Calcium Channel Blockers", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M17412", "name": "Vasodilator Agents", "relevance": "LOW"}, {"id": "M7411", "name": "Diuretics", "relevance": "LOW"}, {"id": "M26152", "name": "Sodium Chloride Symporter Inhibitors", "relevance": "LOW"}, {"id": "M4132", "name": "Angiotensin II", "relevance": "LOW"}, {"id": "M289354", "name": "Giapreza", "relevance": "LOW"}, {"id": "M4135", "name": "Angiotensinogen", "relevance": "LOW"}, {"id": "M25789", "name": "Angiotensin II Type 1 Receptor Blockers", "relevance": "LOW"}, {"id": "M28916", "name": "Angiotensin Receptor Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AnAg", "name": "Antihypertensive Agents"}, {"abbrev": "ChanBlk", "name": "Channel Blockers"}, {"abbrev": "VaDiAg", "name": "Vasodilator Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "NaAg", "name": "Natriuretic Agents"}, {"abbrev": "BDCA", "name": "Bone Density Conservation Agents"}, {"abbrev": "VaCoAg", "name": "Vasoconstrictor Agents"}]}}, "hasResults": true}